Navigation Links
Voxiva and Health Dialog Recognize Breast Cancer Awareness Month with Women's Health Programs
Date:10/24/2013

Washington, D.C. (PRWEB) October 24, 2013

In honor of National Breast Cancer Awareness Month, Voxiva, Inc. a pioneer in interactive health and wellness programs, and Health Dialog, a provider of shared health care decision-making aids, are pleased to recognize October as Breast Cancer Awareness Month. The companies are aligned in their efforts to provide individuals with information, support and confidence in managing their health. Voxiva is the developer of txt4health, a text message-based adult wellness program based on US Preventive Services Task Force national preventive health guidelines. Health Dialog has developed a portfolio of decision aids to help individuals in making appropriate medical treatment choices.

Txt4health users receive personalized, interactive text messages based on their gender and age, encouraging them to follow recommended guidelines for physical exams and screenings and reminding them to schedule and attend appointments. Adult women enrolled in Txt4health receive messages alerting them to the importance of annual mammograms and making them aware that early identification of breast cancer increases the potential success of treatment. Several leading health insurers have partnered with Voxiva to offer Txt4health to their Medicaid health plan members.

Health Dialog will be making its patient decision and planning aids on breast cancer publicly available throughout the month of October. The aids can be accessed through the Health Dialog website at http://www.healthdialog.com, or by clicking here.

Health Dialog’s early stage breast cancer and breast reconstruction surgery decision aids help guide patients through all stages of the decision making process, from explaining how to read a pathology report to illustrating what a patient can expect from different types of surgeries. Health Dialog also offers planning aids for patients and families who are having needle or breast biopsies to prepare for what will happen before, during and after the procedures. Patient-friendly explanations of medical terms, comparisons of treatment choices, photos, videos, diagrams, and a printable booklet enable patients to become active, engaged and informed as they make the medical decisions that are best for them.

"Voxiva is committed to providing personalized information, support, motivation and confidence to help each individual be as healthy as they can be. We hope that Txt4health's preventive guidance regarding breast cancer screening will help many women achieve that goal," said Paul Meyer, Voxiva’s Chairman & President.

“Facing a breast cancer diagnosis can be overwhelming so we’re proud to be working with Voxiva to jointly promote our resources for women with breast cancer,” said Robert Mandel, MD, Chief Executive Officer, Health Dialog. “At Health Dialog, we believe information is one of the best tools a patient can arm themselves with. All of our efforts in support of National Breast Cancer Awareness Month are in the interest of providing women and their families with access to information that will help them better understand their condition and treatment options so they can feel more confident when making critical decisions.”

For more information, email Voxiva at info(at)voxiva(dot)com.

###

About Voxiva, Inc.
Founded in 2001, Voxiva is a global pioneer in delivering interactive mobile health services to help people live the healthiest life possible. The company's Care4life product portfolio combines evidence-based health guidelines, state-of-the-art behavior change expertise and digital technology to promote maternal & child health, adult health & wellness, smoking cessation and diabetes self-management. Personalized health information is sent via text messaging, mobile web and mobile applications.

In 2011, Fast Company recognized Voxiva as one of the 50 Most Innovative Companies in the world. Learn more at http://www.voxiva.com or contact info(at)voxiva(dot)com.

About Health Dialog Services Corporation:
Health Dialog Services Corporation is a leading provider of healthcare analytics and decision support. The firm is a private, wholly-owned subsidiary of Bupa, a global provider of healthcare services. Health Dialog helps health plans, employers and physician groups improve healthcare quality while reducing overall costs. Company offerings include health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. Health Dialog helps individuals participate in their own healthcare decisions, develop more effective relationships with their physicians, and live longer, healthier, happier lives. For more information, visit http://www.healthdialog.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11261284.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Voxiva Works with Aetna to Deliver Personalized Diabetes Support to Delaware Physicians Care Members via Mobile Phone
2. Voxiva, Leader in Mobile Health and Wellness, Reaches Milestone
3. You Survived Cancer: Now Pay Attention to Your Overall Health
4. NIH awards $20 million over 5 years to train next generation of global health researchers
5. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
6. Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says
7. Climate Change Could Be Tough on Seniors Health: Study
8. Supporting LGB children may influence their long-term health, BU study finds
9. U.S. Spends Too Little on Public Health Initiatives: Report
10. Optimal care of bariatric surgery patients vital for long-term health and well-being
11. Timing pregnancy an important health concern for women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... , ... Are You Concerned About Mold In Your Home or Workplace? ... Companies in VA, MD and DC, recently completed its application for the new District ... in the district of Columbia is a good thing stated John Taylor, Owner of ...
(Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
(Date:12/2/2016)... Los Angeles, CA (PRWEB) , ... December 02, 2016 , ... For over twenty-four years, ... a lien basis to help personal injury victims find high quality medical care. When ... the Los Angeles area. Fast forward to present day and the now ten-page directory ...
(Date:12/2/2016)... ... December 02, 2016 , ... FlexiSpot, ... of its 60-day free trial program for all of the company’s desktop riser ... a truly hassle free experience. , FlexiSpot’s unique desktop risers use an advanced ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, 2016 , ... ... Through an exclusive interview with Mediaplanet, Dr. Murthy explains how he was inspired to ... “Early on I learned that medicine is about more than making diagnoses and prescribing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Seno Medical Instruments, Inc., the company pioneering the development ... the process of diagnosing breast cancer, today announced that ... surveillance and clinical follow-up study at the 2016 ... from December 6-10, 2016 at the Henry B. Gonzalez ... . Seno Medical Instruments will present two ...
(Date:12/5/2016)... and TAIPEI, Taiwan , Dec. ... months of treatment ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) ... a significantly better safety and tolerability profile of ropeginterferon alfa-2b ... from PROUD-PV and the ongoing long-term follow-up trial CONTINUATION-PV to ... PharmaEssentia intends to present this data to the FDA ...
(Date:12/4/2016)... 3, 2016 Sickle cell disease (SCD) is ... blood cells that get stuck in veins and block ... failure, and complications leading to death. Each year, approximately ... and most of them lack access to comprehensive care ... long-term therapy for SCD, a pill called hydroxyurea approved ...
Breaking Medicine Technology: